Effect of short-term hormone therapy on oxidative stress and endothelial function in African American and Caucasian postmenopausal women

Fertility and Sterility

Volumn 79, Issue 5, 2003, Pages 1118-1122

  Ke, Raymond W ^a   Pace, Diane Todd ^a   Ahokas, Robert A ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

African American women; Caucasian women; Hormone therapy; Menopause; Nitric oxide; Oxidative stress

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; BIOLOGICAL MARKER; CADMIUM; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTROGEN; FREE RADICAL; GESTAGEN; NITRATE; NITRIC OXIDE; NITRITE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CAUCASIAN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; FUNCTIONAL ASSESSMENT; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; MENOPAUSAL SYNDROME; METABOLITE; NEGRO; OXIDATION; OXIDATIVE STRESS; POSTMENOPAUSE; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SHORT COURSE THERAPY; SMOKING; STATISTICAL SIGNIFICANCE; VASCULAR ENDOTHELIUM;

EID: 0037624668     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(03)00153-5     Document Type: Article

References (17)

1. Stampfer M.J., Willet W.C., Colditz J.A., Rosner B., Speizer F.E., Hennekens C.H. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med. 313:1985;1044-1049.
2. Subbiah M.T.R., Kessel B., Agrawal M., Rajan R., Abplanalp W., Rymaszewski Z. Antioxidant potential of specific estrogens on lipid peroxidation. J Clin Endocrinol Metab. 77:1993;1095-1097.
3. Guetta V., Quyyumi A.A., Prasad A., Panza J.A., Waclawiw M., Cannon R.O. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. Circulation. 96:1997;2795-2801.
4. Nabulsi A.N., Folsom A.R., White A., Patsch W., Heiss G., Wu K.K., et al. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med. 328:1993;1069-1075.
5. Lenfant C. Report of the NHLBI working group on research in coronary heart disease in blacks. Circulation. 90:1994;1613-1623.
6. Nicholson W.K., Brown A.F., Gathe J., Grumbach K., Washington A.E., Perez-Stable E.J. Hormone replacement therapy for African American women missed opportunities for effective intervention . Menopause. 6:1999;147-155.
7. Patrono C., Fitzgerald G.A. Isoprostanes potential markers of oxidant stress in atherothrombotic disease . Arterioscler Thromb Vasc Biol. 17:1997;2309-2315.
8. Haliwell B., Grootveld M. The measurement of free radical reactions in humans. Some thoughts for future experimentation. FEBS Lett. 213:1987;9-16.
9. Bhavnani B.R., Cecutti A., Gerulath A., Woolever C.A. Are cardiovascular benefits associated with conjugated equine estrogen therapy and red wine consumption a result of the antioxidant properties of their components? J Soc Gynecol Invest. 4:(Suppl 1):1997;106A.
10. Bhavnani B.R., Cecutti A., Dey M.S. Biologic effects of delta-8-estrone sulfate in postmenopausal women. J Soc Gynecol Invest. 5:1998;156-160.
11. Santanam N., Shern-Brewer R., McClatchey R., Castellano P.Z., Murphy A.A., Voelkel S., et al. Estradiol as an antioxidant incompatible with its physiological concentrations and function . J Lipid Res. 39:1998;2111-2118.
12. Morrow J.D., Hill K.E., Burk R.F., Nammour T.M., Badr K.F., Roberts L.J. A series of prostaglandin F2-like compounds are produced in vivo by humans by a non-cyclo oxygenase free radical catalyzed mechanism. Proc Natl Acad Sci USA. 87:1990;9383-9387.
13. Cisinelli E., Ignarro L.J., Lograno M., Matteo G., Falco N., Schonauer L.M. Acute effects of transdermal estradiol administration on plasma levels of nitric oxide in postmenopausal women. Fertil Steril. 67:1997;63-66.
14. Lieberman E.H., Gerhard M.D., Uehata A., Walsh B.W., Selwyn A.P., Ganz P., et al. Estrogen improves endothelium dependent, flow mediated vasodilation in postmenopausal women. Ann Intern Med. 121:1994;936-941.
15. Tagawa H., Shimokawa H., Tagawa T., Kuroiwa-Matsumoto M., Hirooka Y., Takeshita A. Short-term estrogen augmnets both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilation in postmenopausal women. J Cardiovasc Pharmacol. 30:1997;481-488.
16. Imthurn B., Rosselli M., Jeager A.W., Keller P.J., Dubey R.K. Differential effects of hormone replacement therapy on endogenous nitric oxide levels in postmenopausal women substituted with 17-β-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate. J Clin Endocrinol Metab. 82:1997;388-394.
17. Bazargan M. The effects of health, environmental, socio-psychological variables on fear of crime and its consequences among urban black elderly individuals. Int J Aging Hum Dev. 38:1994;99-115.